Acro Biomedical Co., Ltd.
ACBM· OTC
ACBMAcro Biomedical Co., Ltd.
Filed Jan 16, 2018 · 10-K · 108 days after period end · 0001640334-18-000094
derived · Computed from the longer spans the company filed.
| Metric | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures |
|---|---|---|---|
| Net Income | $39.50K | -$6.13K | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Acro Biomedical Co., Ltd. · CIK 1622996 · Engraved from SEC EDGAR
ended Sep 30, 2017 · filed Jan 16, 2018 · 108 d after period end
